IL6 and systemic lupus erythematosus: Notably, RHSL reduced the secretion levels of IL-6 and TNF-α in PBMCs from SLE patients in a dose-dependent manner, with significant effects observed particularly at a concentration of 100 μg/mL (Figure 6C,D).